Maybe thats the news that will help fill the gap. $0.21 (old resistance) seems to be a consolidation level before closing the gap @$0.3 on new news
$SGMO
𝐀𝐒𝐂𝐎 𝟐𝟎𝟐𝟔: @AllogeneTx announced a CEO succession plan late last week. The two leaders behind it discuss why now is the right time, and update us on the progress of the company's programs. $ALLO#ASCO26
Full video: biotechtv.com/post/allogene-…